Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

GenomicTree Inc Company Overview 4

GenomicTree Inc Company Snapshot 4

GenomicTree Inc Pipeline Products and Ongoing Clinical Trials Overview 4

GenomicTree Inc – Pipeline Analysis Overview 7

GenomicTree Inc - Key Facts 7

GenomicTree Inc - Major Products and Services 8

GenomicTree Inc Pipeline Products by Development Stage 9

GenomicTree Inc Pipeline Products Overview 11

ASRP KRAS Multiplex PCR Assay 11

ASRP KRAS Multiplex PCR Assay Product Overview 11

ASRP qPCR BRAF Test 12

ASRP qPCR BRAF Test Product Overview 12

EarlyTect - Bladder Cancer 13

EarlyTect - Bladder Cancer Product Overview 13

EarlyTect - Lung Cancer 14

EarlyTect - Lung Cancer Product Overview 14

EarlyTect Breast Cancer 15

EarlyTect Breast Cancer Product Overview 15

EarlyTect Cervical Cancer 16

EarlyTect Cervical Cancer Product Overview 16

EarlyTect Colon Cancer 17

EarlyTect Colon Cancer Product Overview 17

EarlyTect Colorectal Cancer - Recurrence 18

EarlyTect Colorectal Cancer - Recurrence Product Overview 18

GTPlex BRAF/KRAS Mutation Assay 19

GTPlex BRAF/KRAS Mutation Assay Product Overview 19

GTPlex EGFR Mutation Assay 20

GTPlex EGFR Mutation Assay Product Overview 20

GTPlex Respiratory PyroSeq Assay 21

GTPlex Respiratory PyroSeq Assay Product Overview 21

Real-Time PCR Respiratory Virus Assay 22

Real-Time PCR Respiratory Virus Assay Product Overview 22

Screening Test - Cervical Cancer 23

Screening Test - Cervical Cancer Product Overview 23

GenomicTree Inc - Key Competitors 24

GenomicTree Inc - Key Employees 25

GenomicTree Inc - Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

GenomicTree Inc, Recent Developments 27

Jun 07, 2013: Biomarker Identification May Lead To New Noninvasive Test For Colorectal Cancer Detection, Yonsei University College of Medicine And Genomictree Study 27

Appendix 28

Methodology 28

About GlobalData 31

Contact Us 31

Disclaimer 31

Summary

GenomicTree Inc (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung and bladder cancer. GenomicTree's products include novel epigenetic biomarkers and non-invasive accurate cancer detection products. The company's other products comprise infectious diseases detection products, genotypes detection products, methylation profiling systems, single tube products, oncology treatment products, and others. It offers services such as assay development, clinical validation, gene expression microarray services, miRNA microarray, methylation microarray, pyrosequencing, methylation and methylation assay services. The company caters to pharmaceutical and diagnostic sectors. GenomicTree is headquartered in Daejeon, South Korea.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GenomicTree Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company